Director, Discovery Partnerships

Position Summary: Quotient is seeking a Director, Discovery Partnerships to lead the company’s discovery partnerships strategy. This is a senior position critical to achieving our company's objectives in the somatic genomics space. This role is responsible for identifying, developing, and managing strategic partnerships to source human biological samples and associated information essential for our research. The role will be part of the Target Discovery Team and work closely with scientists throughout the company and external collaborators to ensure the successful execution of our research projects.

Responsibilities:

• Lead the identification and prioritisation of potential academic and commercial collaborators to support the company's platform and experimental priorities.

• Lead and maintain positive relationships with current active discovery partners

• Drive evaluation of global discovery partnership opportunities, including scientific and strategic rationale, frameworks, and financial assessments.

• Represent the company in negotiating and structuring discovery partnership agreements, ensuring alignment of goals, expectations, and deliverables.

• Define and align biological sample sourcing requirements for somatic genomics studies.

• Oversee the sourcing and timing of biological sample acquisition.

• Establish and maintain a network of external stakeholders, such as key opinion leaders, university teams and tissue banks, to facilitate effective partnerships.

• Collaborate cross-functionally with scientific, legal, operations, and executive teams to align partnership strategy with research and business priorities.

• Lead operational management of partnerships, including coordination of activities, documentation, financial processes, and compliance, to ensure timely delivery against milestones.

Qualifications:

Essential

• PhD in a life science field or equivalent experience in a genomics or biotech setting.

• Experience in partnerships, alliance management, or business development, with a track record of structuring, negotiating, and closing complex external agreements.

• Demonstrated ability to influence and build trust with diverse stakeholders, including scientists, academics, and external partners.

• Proven ability to manage multiple workstreams simultaneously within a matrix environment.

• Working knowledge of relevant contractual agreements (e.g., Material Transfer Agreements, Research Collaboration Agreements, and Service Agreements).

• Strong written and verbal communication, capable of communicating complex scientific concepts to internal and external stakeholders at various levels.

Desirable

• Working knowledge of relevant regulatory and compliance frameworks (e.g., Human Tissue Authority).

• Experience managing procurement processes, including purchase order creation and tracking budgets to support financial processes.

• Previous background evaluating or sourcing biological samples.

Values and Behaviors:

• Encourage respectful disagreement and cultivate open-minded, ego-free interactions to continuously push each other towards excellence.

• Seek out diverse perspectives; practice active listening and genuine curiosity to ensure all contributions are valued, regardless of source.

• Recognize the impact of your behavior, language and attitudes, and strive for balanced, meaningful exchanges that enhance mutual growth and understanding in all interactions.

• Use a company-first mindset to guide decision-making; prioritize team over individual success.

• Take calculated risks and challenge convention in the quest for exceptional outcomes.

About Quotient: Quotient Therapeutics is a privately-held, early stage company developing breakthrough medicines informed by natural somatic genetic diversity present in patients. Through our work in somatic genomics, we are forging a new status quo for biopharma research and development across a broad pipeline of internal and partnered programs.

The company was founded by Flagship Pioneering, an innovative enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Generate Biomedicines, Sana Biotechnology (SANA), Tessera Therapeutics, Evelo Biosciences (EVLO), Indigo Agriculture, Seres Therapeutics (MCRB), and Syros Pharmaceuticals (SYRS).

Quotient Therapeutics and Flagship Pioneering are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Recruitment & Staffing Agencies: Quotient Therapeutics (“Quotient”) and Flagship Pioneering (“FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Quotient, FSP or their employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.